Drug Shortage Report for ADMELOG SOLOSTAR
Report ID | 160261 |
Drug Identification Number | 02469871 |
Brand name | ADMELOG SOLOSTAR |
Common or Proper name | Insulin lispro |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | INSULIN LISPRO |
Strength(s) | 100UNIT |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 3 mL pre-filled pen, 5 pens/box |
ATC code | A10AB |
ATC description | INSULINS AND ANALOGUES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2022-05-05 |
Estimated end date | 2022-05-13 |
Actual end date | 2022-05-11 |
Shortage status | Resolved |
Updated date | 2022-05-12 |
Company comments | Delay in transportation. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2022-05-12 | English | Compare |
v3 | 2022-05-10 | French | Compare |
v2 | 2022-05-10 | English | Compare |
v1 | 2022-05-10 | English | Compare |
Showing 1 to 4 of 4